| MYCN-driven fatty acid uptake is a metabolic vulnerability in neuroblastoma L Tao, MA Mohammad, G Milazzo, M Moreno-Smith, TD Patel, B Zorman, ... Nature communications 13 (1), 3728, 2022 | 41 | 2022 |
| Targeting oncogenic transcriptional networks in neuroblastoma: from N-Myc to epigenetic drugs R Ciaccio, P De Rosa, S Aloisi, M Viggiano, L Cimadom, SK Zadran, ... International Journal of Molecular Sciences 22 (23), 12883, 2021 | 14 | 2021 |
| Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation D Banerjee, S Bagchi, Z Liu, HC Chou, M Xu, M Sun, S Aloisi, Z Vaksman, ... Nature Communications 15 (1), 3432, 2024 | 9 | 2024 |
| MYOD-SKP2 axis boosts tumorigenesis in fusion negative rhabdomyosarcoma by preventing differentiation through p57Kip2 targeting S Pomella, M Cassandri, L D’Archivio, A Porrazzo, C Cossetti, D Phelps, ... Nature communications 14 (1), 8373, 2023 | 5 | 2023 |
| MYCN Amplification, along with Wild-Type RB1 Expression, Enhances CDK4/6 Inhibitors’ Efficacy in Neuroblastoma Cells P De Rosa, F Severi, SK Zadran, M Russo, S Aloisi, A Rigamonti, ... International Journal of Molecular Sciences 24 (6), 5408, 2023 | 3 | 2023 |